Characterization of the interactions of estrogen receptor and MNAR in the activation of cSrc

Frank Barletta1, Chi-Wai Wong, Chris McNally

  • 1Department of Women's Health and Bone Research, Wyeth Research, 500 Arcola Road, Collegeville, Pennsylvania 19426, USA.

Insights

The scaffold protein MNAR (modulator of nongenomic activity of ER) mediates estrogen receptor alpha (ERalpha) and Src interaction, activating Src kinase. MNAR facilitates ERalpha transcriptional activity and integrates ERalpha actions into Src-mediated signaling pathways.

Area of Science:

  • Molecular biology
  • Cell signaling
  • Protein-protein interactions

Background:

  • Src kinase activity is tightly regulated by intramolecular interactions.
  • Src activation requires specific domain interactions, including SH2 and SH3 domains.
  • Estrogen receptor alpha (ERalpha) plays a role in cellular signaling pathways.

Purpose of the Study:

  • To elucidate the molecular mechanism of Src activation mediated by ERalpha and the scaffold protein MNAR.
  • To define the specific interactions between MNAR, ERalpha, and Src.
  • To understand MNAR's role in integrating ERalpha signaling with Src-mediated pathways.

Main Methods:

  • Site-directed mutagenesis of MNAR, ERalpha, and Src.
  • Functional assays to evaluate Src enzymatic activity and ERalpha transcriptional activity.
  • Co-immunoprecipitation and mapping studies to determine protein-protein interaction domains.

Main Results:

  • MNAR interacts with Src via its SH3 domain's PXXP motif, leading to Src activation.
  • MNAR stabilizes the ERalpha-Src complex through interactions involving ERalpha's Y537 and MNAR's LXXLL motifs.
  • MNAR is essential for ERalpha-induced Src/MAPK pathway activation and ERalpha transcriptional activity.

Conclusions:

  • MNAR acts as a crucial scaffold protein, mediating the interaction between ERalpha and Src.
  • MNAR's interactions are critical for both Src activation and ERalpha's transcriptional function.
  • MNAR plays a significant role in integrating ERalpha signaling into Src-mediated cellular responses.

Related Concept Videos

Drug-Receptor Interactions01:29

Drug-Receptor Interactions

Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.4K
Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
5.0K
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
4.1K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.7K
Receptor-mediated Endocytosis01:39

Receptor-mediated Endocytosis

Overview
110.7K
G-protein Coupled Receptors01:21

G-protein Coupled Receptors

G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
131.7K